跳至主要内容
临床试验/JPRN-UMIN000012967
JPRN-UMIN000012967已完成未知

Randomized control study to evaluate the efficacy of Denosumab versus zoledronic acid for treatment of bone metastases in men with prostate cancer - Randomized control study to evaluate the efficacy of Denosumab versus zoledronic acid for treatment of bone metastases in men with prostate cancer

Chiba Cancer Center0 个研究点目标入组 80 人开始时间: 2014年1月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional,observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1.Patients who had prior bisphosphonate 2.Patients who are on hemodialysis 3.Patients who are treated with chemotherapy 4.Patients with poorly controlled hepatic disorder or renal dysfunction or diabetes 5.Patients who are receiving or planning treatment of tooth extraction or dental implant for oral infeciton 6.Patients who considered inappropriate for this trial by physicians

研究者

发起方
Chiba Cancer Center

相似试验